Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1
- 23 January 2007
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 68 (4) , 295-297
- https://doi.org/10.1212/01.wnl.0000252366.10731.43
Abstract
APTX gene mutations responsible for ataxia–oculomotor apraxia 1 (AOA1) were identified in a family previously reported with ataxia and coenzyme Q10 (CoQ10) deficiency. We measured muscle CoQ10 levels in six patients with AOA1 and found decreased levels in five. Patients homozygous for the W279X mutation had lower values (p = 0.003). A therapeutic trial of CoQ10 may be warranted in patients with AOA1.Keywords
This publication has 9 references indexed in Scilit:
- Restoring balance to ataxia with coenzyme Q10 deficiencyJournal of the Neurological Sciences, 2006
- Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutationNeurology, 2005
- The Effect of HMG-CoA Reductase Inhibitors on Coenzyme Q10Drug Safety, 2005
- Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studiesBrain, 2003
- Differences in coenzyme Q10 content in deltoid and quadriceps musclesClinica Chimica Acta; International Journal of Clinical Chemistry, 2003
- Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily geneNature Genetics, 2001
- The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxinNature Genetics, 2001
- Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiencyThe Lancet, 2000
- Biochemical, physiological and medical aspects of ubiquinone functionPublished by Elsevier ,1999